Connect with us

Health

Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings – News-Medical.Net

Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency…

Published

on

Article feature image

Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending